Inventor

HABER EDGAR

US32 patents

⚠️ This page may combine multiple inventors who share the name “HABER EDGAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HABER EDGAR

GEN HOSPITAL CORP

Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides

Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin

Fibrin-specific antibodies and method of screening for the antibodies

Method for early detection of allograft rejection

Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Renin inhibitors

Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use

Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Composition and method for acceleration of clot lysis

Method and use for site-specific activation of substances

Antibody-thrombolytic agent product and method of use

Monoclonal antidigoxtin antibodies

Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin

Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin

Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin

Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity

HARVARD COLLEGE

Antioxidant-induced apoptosis in vascular smooth muscle cells

Endothelial-cell specific promoter

Fibrin-targeted inhibitors of thrombin

Cellular basis of transplant arteriosclerosis in mice

Smooth muscle cell LIM protein

Smooth muscle cell LIM protein

Cellular basis of vascular-graft stenosis

Smooth muscle cell LIM promoter

MASSACHUSETTS GEN HOSPITAL

Composition and method for determining the size and location of myocardial infarcts

Radiolabeled diagnostic compositions and method for making the same

Antibody fragment compositions and process

Assay for beta-adrenergic antagonists and antibody therefor

Process and composition for reducing blood pressure

IONICS

Process and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrier

Process and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrier

BRISTOL MYERS SQUIBB CO

Methods of inhibiting the activation of Factor XIII